mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.007 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.007 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
-0.35 |
0.008 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |